Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by American Society of Addiction Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Society of Addiction Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality

20:04
 
Share
 

Manage episode 444195907 series 2427869
Content provided by American Society of Addiction Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Society of Addiction Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Host Shawn McNeil, MD, is joined by Michelle Lofwall, MD, DFAPA, DFASAM, a professor in the Department of Behavioral Science and Psychiatry at the University of Kentucky and Medical Director of UK’s Robert Straus and First Bridge Clinics, which provide comprehensive OUD treatment within the UK Center on Drug and Alcohol Research. Dr. Lofwall and her co-authors examined the relationship between the dose in the early stages of treatment and the subsequent risk of death and found some surprising results.

Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality

Journal of Addiction Medicine 18(3):p 319-326, 5/6 2024

May-June 2024

  continue reading

45 episodes

Artwork
iconShare
 
Manage episode 444195907 series 2427869
Content provided by American Society of Addiction Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Society of Addiction Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Host Shawn McNeil, MD, is joined by Michelle Lofwall, MD, DFAPA, DFASAM, a professor in the Department of Behavioral Science and Psychiatry at the University of Kentucky and Medical Director of UK’s Robert Straus and First Bridge Clinics, which provide comprehensive OUD treatment within the UK Center on Drug and Alcohol Research. Dr. Lofwall and her co-authors examined the relationship between the dose in the early stages of treatment and the subsequent risk of death and found some surprising results.

Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality

Journal of Addiction Medicine 18(3):p 319-326, 5/6 2024

May-June 2024

  continue reading

45 episodes

すべてのエピソード

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play